Skip to main content

Want a detailed portfolio tracker?

Polypid (PYPD) P/E (2020 - 2026)

Polypid (PYPD) P/E from Dec 31, 2020 to Jul 21, 2026. The TTM Polypid (PYPD) P/E is -1.99. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Polypid (PYPD)

YearP/EChange
2026-1.99-13.82%
2025-2.31+116.58%
2024-1.07-36.19%
2023-1.67-81.84%
2022-9.21-87.85%
2021-75.82-49.11%
2020-148.98N/A

Comparison Polypid (PYPD) P/E with competitors

Polypid (PYPD) P/E is -1.99.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.00-100.22%
ENLVEnlivex Ltd0.07-103.75%
FGENFibroGen Inc0.24-112.05%
CHRSCoherus Biosciences Inc0.85-142.59%
FBIOFortress Biotech Inc0.95-147.63%
ORMPOramed Pharmaceuticals Inc1.50-175.43%
AGENAgenus Inc3.01-251.04%
INVAInnoviva Inc3.15-258.29%
VXRTVaxart Inc3.55-278.15%
CRMDCorMedix Inc3.63-282.10%
CVACCureVac N.V.4.45-323.11%
GLPGGalapagos NV4.86-343.85%
SRPTSarepta Therapeutics Inc4.88-345.02%
ABEOAbeona Therapeutics Inc5.39-370.38%
ABUSArbutus Biopharma Corp5.60-380.83%
ZVRAZevra Therapeutics Inc5.89-395.46%
SPROSpero Therapeutics Inc6.23-412.59%
CGENCompugen Ltd6.31-416.88%
RIGLRigel Pharmaceuticals6.87-444.89%
SLXNSilexion Therapeutics Corp7.30-466.17%
OMEROmeros Corporation9.26-564.67%
AUPHAurinia Pharmaceuticals Inc9.58-581.04%
PLXProtalix BioTherapeutics Inc10.89-646.59%
ACADAcadia Pharmaceuticals Inc11.73-688.62%
TBPHTheravance Biopharma Inc12.26-715.40%
ADMAAdma Biologics Inc12.42-723.23%
HRMYHarmony Biosciences Holdings Inc13.82-793.59%
SABSSAB Biotherapeutics Inc14.14-809.45%
NAGENiagen Bioscience Inc14.82-843.68%
INCYIncyte Corp15.82-894.09%
REGNRegeneron Pharmaceuticals Inc15.86-895.80%
PBYIPuma Biotechnology Inc17.32-969.02%
CPRXCatalyst Pharmaceuticals Inc17.44-975.23%
EXELExelixis Inc17.54-980.18%
TGTXTG Therapeutics Inc18.97-1051.85%
MDXGMimedx Group Inc20.55-1131.47%
XOMAXOMA Royalty Corp22.87-1248.04%
ARGXArgen X SE24.30-1319.48%
CTMXCytomX Therapeutics Inc24.82-1345.73%
XOMAOXOMA Royalty Corp25.34-1372.01%
HALOHalozyme Therapeutics Inc25.62-1386.01%
XOMAPXOMA Royalty Corp25.67-1388.34%
VRTXVertex Pharmaceuticals Inc27.99-1505.01%
RPRXRoyalty Pharma plc - Class A28.69-1539.78%
SLNOSoleno Therapeutics Inc29.02-1556.23%
ASNDAscendis Pharma A/S30.09-1609.94%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2002.74%
APLSApellis Pharmaceuticals Inc39.02-2058.41%
BMRNBiomarin Pharmaceutical Inc42.21-2218.54%
KRYSKrystal Biotech Inc45.34-2375.71%
ONCBeiGene Ltd69.54-3590.12%
PHARPharming Group N.V.75.03-3865.41%
TECHBio-Techne Corp101.96-5217.13%
VCELVericel Corp109.92-5616.77%
ALNYAlnylam Pharmaceuticals Inc117.96-6020.48%
GMABGenmab140.29-7140.97%
TLXTelix Pharmaceuticals Ltd162.15-8238.19%
CORTCorcept Therapeutics Inc212.86-10782.97%